<< Mercury Home

Comparative Analysis:
Weldon H.R. 881 to Mercury Free Drug Act 2005 (MFDA)

KEY ISSUE

HR 881 PROVISIONS

MFDA PROVISIONS

Coverage

Vaccines Only

ALL Drugs

Mercury Limit

Less than (LT) 1.0 mcg per dose for vaccines.

VACCINES:

Not more than (NMT) 1.0 mcg total mercury per dose for vaccines with NMT 0.5 mcg per dose of organic mercury compounds.

OTHER DRUGS:

NMT 0.5 mcg per dose for drugs given less than 3 times a year.

NMT 0.03 mcg per dose for drugs given in a short-term regimen with NMT 3 doses per day.

NMT 0.01 mcg per dose for drugs given in long-term treatment regimens with more than 50 doses.

[NOTE: For comparison, the EPA upper limit for Potable Water is NMT 0.002 ppb.]

Proof Of Safety 1 Required

 

No

Yes.

1.   In-depth chronic studies are required unless mercury level is NMT 0.01 mcg per dose.

2.   Simpler chronic studies if you add no mercury to the product and the total level of mercury is NMT 0.005 mcg per dose.

1   Since no proper studies for the long-term harm of mercury in vaccines have ever been done, there is no proof of safety.  Therefore, effectively, the Mercury-Free Drugs Act 2005 would disallow mercury, at any level, except for accidental component levels. 

Disclosure Requirements

And

Restrictions

Only presence of mercury – not its level or the nature of the compound.

 

Availability of mercury-free, or mercury-reduced, alternatives and how one can obtain such.

 

Recommendation2 against any mercury containing vaccine to a pregnant woman

Compound and level of mercury in parts per billion (1000 times the ppm level).

 

Availability of mercury-free, or mercury‑reduced, alternatives and how one can obtain such.

 

VACCINES: Black box warning on any mercury-preserved vaccine prohibiting its being given to pregnant women and children 3 years of age and younger.

 

ALL DRUGS, DEVICES & COMBINATION PRODUCTS: Manufacture must disclose mercury content on all labeling3 and provide warnings for children and pregnant women

 

2 Not prohibited    3 Required on ALL package insets, cartons, and primary container.

DATES EFFECTIVE

July 1, 2006 for Childhood vaccines

January 1, 2009 for ALL other vaccines.

NMT 180 days after enacted (flu vaccine).

NMT 360 days after enacted (childhood vaccines)

NMT 540 days after enacted (other drugs, devices & all other products).

EXEMPTIONS

Unlimited4 12-month exemption for any “possible” emergency

Limited to a one time only 12-month exemption

4 A “loophole” that may be used to significantly delay the effective dates of compliance.


                                                           
Closing remarks:

The manufacturers, on their own (with a push from the vaccine injured consumer) have already reduced the mercury levels in most vaccines to 0 .5 micrograms or less per dose with the exception of the flu vaccine.  The Weldon bill: a) raises the level to 1 microgram b)  requires no explicit proof of safety, c) is limited to vaccines, d) provides no incentive to stop using mercury compounds in the vaccine manufacturing process. 

Rather than demanding the complete removal of mercury from the process at a time when the vaccine manufacturers have been given tax credits to build new vaccine facilities, the Weldon bill, effectively, continues to support the use of mercury in old or new facilities.  The Weldon bill by law, “reduces” the levels of mercury in vaccines so that less children but not all children will be harmed.  The unnecessary sacrificing of some children but not all children is unacceptable and an unnecessary strategic compromise.

In addition, the current “reduction” process that adds mercury, then “reduces it out” is an antiquated procedure that unnecessarily generates hazardous mercury wastes, which contribute to the poisoning of our environment.  [There are other vaccine-approved sterilizing compounds that are approved for use in vaccines as preservatives that are not mercury based.]

In contrast, the MFDA: a) applies to all drug, device, and combination products, b) explicitly requires proof of safety and since there is no long term proof of safety effectively, MFDA disallows mercury in vaccines and drugs at any level except at accident components levels c) provides strong incentives for the manufacturers to switch to processes that do not involve the use of mercury.

The MFDA also sets mercury level limits on all drugs, except vaccines, that decrease the allowable levels of mercury based on an assessment of average “frequency of use” of the drug or device.

Remember Mercury has not been proven safe at any level.    FMI:    NCOWmail@aol.com 

 
For more information or to help us build this site, contact us